BioMarin Pharmaceuticals BMRN Change in Other Current Assets
Change in Other Current Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's change in other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's change in other current assets?
- BioMarin Pharmaceuticals (BMRN) reported change in other current assets of $11.55M in Q1 2026.
- How has BioMarin Pharmaceuticals's change in other current assets changed year-over-year?
- BioMarin Pharmaceuticals's change in other current assets increased by 82.6% year-over-year, from $6.33M to $11.55M.
- What does change in other current assets mean?
- The change in miscellaneous short-term assets.
- How do you interpret change in other current assets?
- Changes are typically driven by timing of prepayments; large, persistent increases can indicate inefficient use of working capital.
- How does change in other current assets compare across companies?
- Generally a minor line item for most companies, comparable across sectors.